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The complex human T-cell leukemia virus type 1 (HTLV-1) retrovirus encodes several proteins that are
unique to the virus within its 3-end region. Among them, the viral transactivator Tax and posttranscriptional
regulator Rex are well characterized, and both positively regulate HTLV-1 viral expression. Less is known
about the other regulatory proteins encoded in this region of the provirus, including the recently discovered
HBZ protein. HBZ has been shown to negatively regulate basal and Tax-dependent HTLV-1 transcription
through its ability to interact with specific basic-leucine zipper (bZIP) proteins. In the present study, we found
that HBZ reduces HTLV-1 transcription and virion production. We then characterized the interaction between
HBZ and the cellular transcription factor CREB. CREB plays a critical role in Tax-mediated HTLV-1
transcription by forming a complex with Tax that binds to viral cyclic AMP-response elements (CREs) located
within the viral promoter. We found that HBZ and CREB interact in vivo and directly in vitro, and this
interaction occurs through the bZIP domain of each protein. We also found that CREM-Ia and ATF-1, which
share significant homology in their bZIP domains with the bZIP domain of CREB, interact with HBZ-bZIP.
The interaction between CREB and HBZ prevents CREB binding to the viral CRE elements in vitro and in vivo,
suggesting that the reduction in HTLV-1 transcription by HBZ is partly due to the loss of CREB at the
promoter. We also found that HBZ displaces CREB from a cellular CRE, suggesting that HBZ may deregulate
CREB-dependent cellular gene expression.
Human T-cell leukemia virus type 1 (HTLV-1) is a human
retrovirus that is associated with two distinct diseases: adult
T-cell leukemia (ATL), an abnormal proliferation of infected
CD4 T lymphocytes, and HTLV-1-associated myelopathy
and/or tropical spastic paraparesis, a neurodegenerative disor-
der (19, 48, 49). The molecular mechanisms leading to the
development of both diseases are unclear, although the viral
protein Tax is postulated to play an important role in these
processes. Tax functions as a transcription factor and is essen-
tial for strong HTLV-1 transcription. Tax activates transcrip-
tion through three 21-bp repeats that contain imperfect cyclic
AMP responsive elements (called viral CREs) situated within
the long terminal repeat of the HTLV-1 genome (1, 6, 14, 15,
22, 27). Tax does not bind DNA alone but interacts with
cellular transcription factors from the ATF/CREB family to
form complexes that associate with the DNA. Within these
complexes, Tax contacts the GC-rich sequences flanking the
CRE core (31, 37, 38, 41). The formation of Tax/CREB/DNA
complexes is critical for the recruitment of the cellular coacti-
vators CBP/p300 and subsequent high transcriptional activa-
tion of the virus (18, 21, 32, 39, 58).
A number of cellular factors containing basic leucine zipper
(bZIP) motifs have been shown to bind the viral CREs in
HTLV-1-infected T cells. These factors included the ATF/
CREB family members (ATF-1, ATF-2, CREB, CREB-2, and
CREM) and the AP-1 family members (c-Jun and c-Fos) (34;
reviewed in reference 23). Of these factors, CREB has been
shown to play a critical role in Tax-mediated HTLV-1 tran-
scription (8), although the other ATF/CREB members also
form a complex with Tax and activate viral transcription (14,
16). In contrast, c-Jun and c-Fos have been shown to partici-
pate in HTLV-1 basal transcription (28).
Recently, we characterized a novel HTLV-1 protein en-
coded by the complementary strand of the proviral genome,
termed HTLV-1 bZIP factor or HBZ (17). This protein
possesses a putative bZIP domain. Among the bZIP pro-
teins that participate in HTLV-1 transcription, CREB-2 and
c-Jun have been found to interact with HBZ (5, 17, 42).
These interactions occur through the bZIP domain of each
protein. The interaction with CREB-2 suppresses Tax-de-
pendent viral transcription (17), whereas the interaction
with c-Jun reduces AP-1 transcription and also HTLV-1
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basal transcription (5, 42). However, the molecular mecha-
nisms involved in the downregulation of HTLV-1 transcrip-
tion by HBZ have not been completely elucidated. For this
reason, we were interested in studying the effect of HBZ on
CREB, since CREB is a major player in Tax-mediated
HTLV-1 transcription (8). We first confirmed that HBZ
represses HTLV-1 virion production. We then demon-
strated that HBZ binds to CREB in vivo and in vitro, and
this interaction is mediated by the bZIP domain of each
protein. Interestingly, CREM-Ia and ATF-1, which share
significant homology in their bZIP domain with CREB (53),
are also found to interact with HBZ-bZIP. A truncated form
of HBZ, containing the bZIP domain, inhibits CREB bind-
ing to a viral CRE in vitro, whereas HBZ with the bZIP
domain deleted fails to inhibit CREB binding. Using the
chromatin immunoprecipitation (ChIP) assay, we show that
Tax and CREB binding at the HTLV-1 promoter are re-
duced in cells expressing HBZ. These results indicate that
HTLV-1 transcriptional repression by HBZ is, in part, me-
diated by the loss of Tax and CREB binding at the viral
promoter. Finally, we found that HBZ also represses CREB
transcription from a cellular CRE, extending the repressive
role of the HBZ protein to CREB-dependent transcription
of cellular genes.
MATERIALS AND METHODS
Cell culture, transient-cotransfection assays, and expression plasmids. CEM,
MT-4, and C8166-45 cells were cultured in Iscove modified Dulbecco medium
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and penicillin-
streptomycin. The CHOK1-Luc hamster ovary cells (47) and 293T cells were
grown in Dulbecco modified Eagle medium supplemented with 10% fetal bovine
serum. Geneticin (500 g/ml; Invitrogen) was added to CHOK1-Luc cells. For
transient-transfection assays of 293T cells with HTLV-1 proviral DNA clones,
the CalPhos mammalian transfection kit was used according to the manufactur-
er’s instructions (Clontech BD Biosciences). Quantification of HTLV-1 p19
antigen was performed by using an enzyme-linked immunosorbent assay
(ELISA) HTLV-1 p19 antigen kit (Zeptometrix, Buffalo, NY) as described by
the manufacturer. For transient-transfection assays of CEM cells with HTLV-1
proviral DNA clones, plasmids were transfected with a Nucleofector according to
the manufacturer’s instructions (Amaxa Biosystems). For the transient-cotrans-
fection assays shown in Fig. 6A, the cells were grown to a density of 106 cells/ml
and transfected with DMRIE-C (Invitrogen) and a constant amount of DNA for
5 h. The cells were allowed to recover for 24 h before harvest in the presence of
20 M forskolin (Sigma) or dimethyl sulfoxide (carrier). The cells were lysed,
and the luciferase activity was measured by using a dual-luciferase reporter assay
system with a Turner Designs model TD 20-e luminometer. The luciferase
activity was normalized to pRL-TK (Promega), which encodes the Renilla lucif-
erase from the HSV-TK promoter, as an internal control. Expression plasmids
for HBZ (pcDNA-HBZ-MycHis [55]) and Tax (pSG-Tax [51]) have been de-
scribed elsewhere. To construct the plasmid pcDNA-HBZATG, both HBZ
ATGs in pcDNA-HBZ-MycHis were replaced by TAG with a QuikChange
site-directed mutagenesis kit (Stratagene). To construct the plasmid pcDNA-
HBZ-bZIP, HBZ (amino acids [aa] 1 to 132) was amplified by PCR and cloned
into the EcoRI and HindIII sites of pcDNA-MycHis (Invitrogen). The luciferase
reporter plasmids K30-Luc (33), pminLuc-cellular CRE (20), and the HTLV-1
molecular clones ACH (30) have also been described. The Western blots in Fig.
1 were probed with an anti-Myc antibody to detect HBZ (9E10; Sigma) and an
anti-nucleolin antibody (Santa-Cruz).
Expression and purification of recombinant proteins. The expression plasmid
pGST-CREB-His6, provided by C.-Z. Giam (24), and the expression plasmid for
CREM-Ia-bZIP, provided by A. E. Keating (44), were transformed in Esche-
richia coli BL21(DE3)/pLysS (Stratagene), and the proteins were expressed and
purified by Ni2 chelate chromatography as described by the manufacturer
(QIAGEN). The pRSET-HBZ-bZIP (aa 1 to 122) plasmid was constructed by
cloning the HBZ truncation mutant, amplified by PCR, into the pRSET-A vector
(Invitrogen). This plasmid was transformed in the E. coli BL21 codon plus (DE3)
(Stratagene), and the protein was expressed and purified by Ni2 chromatogra-
phy. pGST-HBZ-bZIP (aa 123 to 209) (17) was transformed into E. coli
BL21(DE3)/pLysS, expressed, and purified by glutathione-agarose affinity chro-
matography. Bacterial expression plasmids for human CREB (14), CREB-bZIP
(aa 254 to 327) (26), HBZ-bZIP (aa 123 to 209) (17), and Tax (59) were
transformed into E. coli BL21(DE3)/pLysS, and the proteins were expressed and
purified as described previously (21, 26). The final HBZ-bZIP purified protein
product was composed of two bands, both recognized by an anti-histidine anti-
body. Protein identification analysis via trypsin digest and tandem mass spec-
trometry positively matched the central portions of both protein bands to the
HBZ amino acid sequence and identified the lower band as a C-terminal trun-
cation of the upper band. All proteins were purified to near homogeneity,
dialyzed against 0.1 M TM (50 mM Tris-HCl [pH 7.9], 100 mM KCl, 12.5 mM
MgCl2, 1 mM EDTA [pH 8.0], 20% glycerol, 0.025% [vol/vol] Tween 20, 1 mM
dithiothreitol [DTT]), divided into aliquots, and stored at 70°C.
GST pull-down assays. All GST pull-down experiments were performed with
20 l of glutathione-agarose beads equilibrated in 0.5 Superdex buffer (1
Superdex buffer is 25 mM HEPES [pH 7.9], 12.5 mM MgCl2, 10 M ZnSO4, 150
mM KCl, 20% [vol/vol] glycerol, 0.1% Nonidet P-40, 1 mM EDTA, 2 mM DTT,
and 2 mM phenylmethylsulfonyl fluoride [PMSF]), except for those shown in Fig.
3B (20 mM HEPES [pH 7.9], 2.5 mM MgCl2, 5 M ZnSO4, 25 mM KCl, 10%
[vol/vol] glycerol, 0.05% Nonidet P-40, 1 mM DTT, and 1 mM PMSF) and Fig.
3D and G, left panel (0.5 TM: 25 mM Tris, 50 mM KCl, 7.25 mM MgCl2, 10%
[vol/vol] glycerol, 0.05% Tween 20, 1 mM DTT, and 1 mM PMSF). The purified
glutathione S-transferase (GST) fusion protein was incubated with the glutathi-
one agarose beads for 1 h at 4°C and then washed with binding buffer. The
second protein was then added to the washed beads and incubated for 1 h (or
overnight) at 4°C. Purified bovine serum albumin (BSA) used in Fig. 3H was
purchased from New England Biolabs. The beads were washed with binding
buffer, and bound proteins were eluted with sodium dodecyl sulfate (SDS)
sample dyes. Bound proteins were separated by electrophoresis on SDS-PAGE
gels, transferred to nitrocellulose, and probed with the appropriate antibody. The
antibodies anti-CREB (C-21 and X-12; Santa Cruz Biotechnology) and anti-His
(H-15; Santa Cruz Biotechnology) were used in the present study. For GST
pull-down assays with 35S-labeled proteins (Fig. 3F, right portion of panel G, and
H), plasmids pcDNA-HBZ-MycHis, pRSET-HBZ-bZIP, and ATF-1 (2) were
used to produce HBZ, HBZ-bZIP, and ATF-1, respectively, using the TNT-
Quick-Coupled transcription-translation kit (Promega).
Coimmunoprecipitation assays. Lysates from HTLV-1-infected T cells (MT-4
and C8166-45) and CHOK1-Luc cells transfected with pcDNA3.1 or pcDNA-
HBZ-MycHis were prepared in radioimmunoprecipitation assay (RIPA) buffer
(50 mM Tris-HCl [pH 8.0], 1% Triton X-100, 100 mM NaCl, 1 mM MgCl2, 2 mM
benzamidine, 2 g of leupeptin/ml, and 1 mM PMSF). Antibody-bound beads
(preimmune serum, HBZ serum [17], or Myc antibody [Abcam]) were washed in
RIPA buffer, and cell lysates (500 g) were added to each antibody-bead sus-
pension, incubated overnight, and washed several times in RIPA buffer. The
bound proteins were analyzed on a 10% SDS-polyacrylamide gel and detected by
Western blotting with a mouse anti-CREB-1 antibody (X-12 for Fig. 2A and C-21
for Fig. 2B; Santa Cruz Biotechnology) and Myc antibody (Abcam).
Gel shift assays. Gel shift assays with recombinant proteins were performed as
previously described (21). Briefly, the indicated amounts of purified DNA-bind-
ing proteins and HBZ-bZIP were incubated with 2 to 10 fmol of 32P-end-labeled
double-stranded DNA probe and 5 ng of poly(dA)poly(dT) DNA per reaction
in 0.5 TM 0.1 M. Binding reactions were incubated on ice for 30 min and
resolved on 5% nondenaturating polyacrylamide gels. Gels were dried, and
complexes were visualized by PhosphorImager analysis. The DNA probes have
been described elsewhere (2, 21). The viral CRE is from the promoter-proximal
21-bp repeat, and the cellular CRE is from the human chorionic gonadotropin
gene. Antibodies used for supershift experiments were directed against CREB-1
(X-12; Santa Cruz Biotechnology) and histone H3 (06-755; Upstate).
ChIP assay. For the ChIP experiments the cells were electroporated as de-
scribed previously (35). Briefly, 2  107 cells were electroporated with the
GenePulser Xcell (Bio-Rad) in the presence of 20 g of total DNA. The cells
were harvested 24 h later for luciferase and ChIP analyses. The ChIP assay was
performed essentially as described previously (34). CREB antibody was pur-
chased from Upstate (antibody 06-863). The Tax monoclonal antibody (168B17-
46-34) was obtained from the NIH AIDS Research and Reference Reagent
Program.
Real-time PCR. Real-time PCR and data analysis were performed with an
iCycler and the optical assembly unit (Bio-Rad). Reactions were done by using
the iQ SYBR green Supermix (Bio-Rad) as described previously (34). The PCR
primers for the HTLV-1 promoter were AATGACCATGAGCCCCA and
GTGAGGGGTTGTCGTCA. Standard curves were generated for primer
sets using fivefold serial dilutions of CHOK1-Luc input DNA from the ChIP
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and were included on each experimental plate. PCR efficiencies ranged from
95 to 105%, with correlation coefficients greater than 0.99. Quantitation was
done by comparing threshold cycle values for coimmunoprecipitated DNA to
the threshold cycle value for the input DNA in each ChIP experiment as
described previously (13).
RESULTS
HBZ represses HTLV-1 virion production. We have previ-
ously shown that HBZ represses basal and Tax-dependent
transcription from the HTLV-1 promoter and that these effects
occur specifically through the viral CREs within the promoter
(5, 17). We were interested in extending these studies by ana-
lyzing the effects of HBZ on virion production from the com-
plete HTLV-1 proviral genome. The effect of HBZ was first
tested in the context of a proviral DNA clone containing a
luciferase reporter gene inserted in frame with the envelope
amino acid sequence (33). This construct was derived from the
K30 proviral DNA clone without altering the splice donor site
for multiply spliced mRNA. This proviral DNA was trans-
fected into 293T cells in the presence of increasing amounts of
the HBZ expression vector pcDNA-HBZ-MycHis. As shown
in Fig. 1A, cotransfection of 293T cells with K30-Luc and the
HBZ expression plasmid led to a dose-dependent reduction in
luciferase activity. In contrast, the vector pcDNA-HBZ-
ATG, in which the ATGs are mutated to prevent production
of the HBZ protein, did not reduce the level of luciferase
activity. This result demonstrates that HBZ negatively regu-
lates the expression of K30-Luc.
The effect of HBZ on virion production was also evaluated
by cotransfecting 293T cells with the HTLV-1 molecular clone
ACH (30) and pcDNA-HBZ-MycHis. Cell culture superna-
tants were harvested 24 h after transfection, and virion pro-
duction was evaluated by quantifying HTLV-1 p19 antigen
production. As shown in Fig. 1B, HBZ reduced the amount of
p19gag in a dose-dependent manner. In contrast, we observed
only a slight decrease in virion production when the HBZ
expression plasmid was substituted with pcDNA-HBZ-ATG.
Similar results were observed with another HTLV-1 molecular
clone, K30 (data not shown). Altogether, our data show that
HBZ represses HTLV-1 virion production.
To determine whether HBZ inhibits viral transcription in T
cells, we cotransfected CEM cells with pcDNA-HBZ-MycHis
and K30-Luc. As in 293T cells, HBZ expression led to a re-
duction in luciferase activity in the T cells (Fig. 1C). We found
that the bZIP domain of HBZ contributed to repression, since
FIG. 1. Repression of HTLV-1 proviral gene expression by HBZ. (A) HBZ abrogates proviral genome expression. 293T cells were cotrans-
fected with K30-Luc (2 g), pcDNA-HBZ-MycHis (1 and 5 g), or pcDNA-HBZATG (5 g) and the -galactosidase-containing reference
plasmid pcDNA-lacZ (2 g). Luciferase assays were performed 48 h after transfection and luciferase activity was normalized to -galactosidase
activity. Reported values are the average luminescence from three experiments and the standard error is indicated. Expression of HBZ was
visualized by Western blot analysis with an anti-Myc antibody (middle panel). Protein standards (in kilodaltons) are indicated at the right.
Nucleolin was probed as a loading control (lower panel). (B) HBZ represses virion production. The ACH molecular clone (5 g), pcDNA-HBZ-
MycHis (1 and 5 g) or pcDNA-HBZATG (5 g), and pcDNA-lacZ (2 g) were cotransfected into 293T cells. Expression of p19gag was measured
24 h after transfection. The results are representative of three experiments. Expression of HBZ was visualized by Western blot analysis with an
anti-Myc antibody (middle panel). Protein standards (in kilodaltons) are indicated at the right. Nucleolin was probed as a loading control (lower
panel). (C) HBZ abrogates proviral genome expression in T cells. CEM T cells were cotransfected with K30-Luc (1 g), pcDNA-HBZ-MycHis
(3 g) or pcDNA-HBZbZIP (3 g), and the -galactosidase-containing reference plasmid pcDNA-lacZ (1 g). Luciferase assays were performed
24 h after transfection and luciferase activity was normalized to -galactosidase activity. Reported values are the average luminescence from three
experiments and the standard error is indicated. Expression of HBZ was visualized by Western blot analysis with an anti-Myc antibody (middle
panel). Protein standards (in kilodaltons) are indicated at the right. Nucleolin was probed as a loading control (lower panel).
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expression of an HBZ mutant lacking the last 74 aa (encom-
passing the bZIP domain) caused less of a reduction in viral
transcription (Fig. 1C). However, the fact that this mutant was
still able to decrease viral transcription suggests that other
regions of HBZ are also potentially involved in regulating this
process. This result contrasts with a previous study showing
that an HBZ mutant with a part of the leucine zipper domain
deleted does not repress HTLV-1 transcription (3). This dis-
crepancy may be explained by the different cell lines used for
each experiment (293T were used in the previous study).
HBZ interacts with CREB in vivo and in vitro. Based on the
ability of HBZ to repress Tax-dependent viral transcription
and interact with CREB-2, we were interested in determining
whether HBZ also binds to CREB. Like CREB-2, CREB is a
member of the ATF/CREB family of transcription factors and
functions in Tax transactivation from the HTLV-1 promoter.
We first performed coimmunoprecipitation experiments to de-
termine whether endogenous HBZ and CREB interact in T
cells chronically infected with HTLV-1. HBZ was immunopre-
cipitated from whole-cell extracts of HTLV-1-infected cells
(MT-4 and C8166-45) using either rabbit anti-HBZ antiserum
or preimmune serum from the same rabbit (17). Both infected
cell lines have been shown to express HBZ (17). Figure 2A
shows CREB present in complexes immunoprecipitated with
HBZ, but not preimmune serum, from both HTLV-1-infected
cell lines.
Since the viral protein Tax also interacts with CREB, we
were interested in determining whether Tax or other viral
proteins are required for the interaction between HBZ and
CREB. We therefore performed coimmunoprecipitation ex-
periments in an uninfected cell line (CHOK1). Cells were
transfected with a control plasmid or the HBZ expression
plasmid pcDNA-HBZ-MycHis. Whole-cell extracts prepared
from transfected CHOK1 cells were immunoprecipitated using
a Myc antibody and subsequently probed for CREB. As in
HTLV-1-infected cells, a CREB-HBZ interaction was de-
tected in CHOK1 cells expressing HBZ-Myc (Fig. 2B), dem-
onstrating that additional viral proteins are not required for
the interaction between HBZ and CREB. Interestingly, a 37-
kDa protein was also detected with the 42-kDa CREB protein.
This lower-molecular-mass protein is likely to be either ATF-1
or CREM, since both of these proteins cross-react with the
CREB antibody, directed against the C terminus of CREB,
and have similar apparent molecular masses. In vitro binding
assays show that both ATF-1 and CREM-Ia interact with HBZ
(see below).
Recently, we and others identified a novel alternative spliced
isoform of HBZ (7, 43, 52). In this isoform, HBZ SP1, the first
amino acids are replaced by four different amino acids. We
transfected CHOK1 cells with a control plasmid or an expres-
sion plasmid for the newly identified isoform (pcDNA-HBZ
SP1-Myc-His) (7) and found by coimmunoprecipitation that
HBZ SP1 also interacts with endogenous CREB (data not
shown).
To determine whether the interaction between HBZ and
CREB is direct, we performed GST pull-down assays. Full-
length HBZ was labeled with 35S in an in vitro transcription-
translation reaction. This protein was combined with either
recombinant GST or CREB carrying an N-terminal GST tag.
Figure 2C shows that HBZ was detected with GST-CREB, but
not GST alone, indicating that CREB interacts directly with
HBZ in vitro (lane 3).
The interaction between HBZ and CREB is mediated
through their bZIP domains. To better map the interaction
between HBZ and CREB, we performed GST pull-down as-
says using a truncated form of HBZ containing the bZIP do-
main (aa 123 to 209; the bZIP domain is located between aa
140 and 209) fused to GST (GST-HBZ-bZIP). The purified
FIG. 2. HBZ and CREB interact in vivo and in vitro. (A) HBZ and CREB interact in HTLV-1-infected cells. Cell extracts from the infected
cell lines MT-4 (lanes 1 to 3) and C8166-45 (lanes 4 to 6) were immunoprecipitated with a preimmune serum (PI) or an HBZ antiserum (-HBZ).
The complexes were separated by SDS-polyacrylamide gel electrophoresis (PAGE), transferred to a nitrocellulose membrane, and probed with an
anti-CREB antibody. A fraction of the whole-cell extract is shown in lane 1. (B) HBZ and CREB interact in uninfected cells. Cell extracts from
CHOK1-Luc cells transfected with empty vector () or an expression plasmid for HBZ tagged with Myc (HBZ-Myc) were immunoprecipitated
with an anti-Myc antibody. The complexes were separated by SDS-PAGE, transferred to a nitrocellulose membrane, and probed with an
anti-CREB antibody (upper panel) or an anti-Myc antibody (lower panel). Protein standards (in kilodaltons) are indicated at the left. The asterisk
indicates the heavy chain of immunoglobulin G. (C) HBZ and CREB interact in vitro. 35S-labeled HBZ was incubated with either GST (10 pmol,
lane 2) or GST-CREB (10 pmol, lane 3). Bound HBZ protein was detected by PhosphorImager analysis. A fraction of the input protein (35%)
is shown in lane 1.
1546 LEMASSON ET AL. J. VIROL.
recombinant protein is shown in Fig. 3A. We first tested the
binding of purified full-length CREB to GST-HBZ-bZIP or to
GST alone. As shown in Fig. 3B, we observed specific binding
of CREB to the bZIP domain of HBZ (lane 3). HBZ-bZIP
carrying a hexahistidine tag was also expressed and purified
from bacteria to perform the inverse experiment. After puri-
fication, we obtained a mixture of two products (Fig. 3C). As
shown in Fig. 3D, both polypeptides interacted with GST-
tagged recombinant CREB. These results support the idea that
the HBZ interaction with CREB occurs through the bZIP
domain of each protein. To test this hypothesis, we analyzed
the binding of GST-HBZ-bZIP with the bZIP domain of
CREB (CREB-bZIP) in a GST pull-down assay. As shown in
Fig. 3E, GST-HBZ-bZIP was found to interact specifically with
FIG. 3. HBZ and CREB interact through their bZIP domains. (A) Purified GST HBZ-bZIP. Purified GST HBZ-bZIP is shown by Coomassie
blue staining after SDS-PAGE (lane 2). Protein standards (in kilodaltons) are indicated in lane 1. (B) CREB interacts with HBZ-bZIP. Purified
CREB (10 pmol) was incubated with either 50 pmol of GST alone (lane 2) or 50 pmol of GST-HBZ-bZIP (lane 3). Bound CREB protein was
detected by Western blot analysis. A fraction of the input protein (8%) is shown in lane 1, and protein standards (in kilodaltons) are indicated at
the left. (C) Purified HBZ-bZIP. Purified HBZ-bZIP is shown by Coomassie blue staining after SDS-PAGE (lane 2). Protein standards (in
kilodaltons) are indicated in lane 1. (D) HBZ-bZIP interacts with CREB. HBZ-bZIP (10 pmol) was incubated with either 10 pmol of GST alone
(lane 2) or 10 pmol of GST-CREB (lane 3). Bound CREB-bZIP protein was detected by Western blot analysis. A fraction of the input protein
is shown in lane 1, and protein standards (in kilodaltons) are indicated at the left. (E) CREB-bZIP interacts with HBZ-bZIP. Purified CREB-bZIP
(50 pmol) was incubated with either 10 pmol of GST alone (lane 2) or 10 pmol of GST-HBZ-bZIP (lane 3). Bound CREB-bZIP protein was
detected by Western blot analysis. A fraction of the input protein (10%) is shown in lane 1, and protein standards (in kilodaltons) are indicated
at the left. (F) HBZ-bZIP domain does not interact with CREB. 35S-labeled HBZ and HBZ-bZIP were incubated with either GST (10 pmol,
lanes 3 and 4, respectively) or GST-CREB (10 pmol, lanes 5 and 6, respectively). Bound proteins were detected by PhosphorImager analysis. A
fraction of the input proteins (15%) is shown in lanes 1 and 2. (G) CREM-Ia-bZIP and ATF-1 interact with HBZ-bZIP. Purified CREM-Ia-bZIP
(50 pmol) was incubated with either 50 pmol of GST alone (lane 2) or 50 pmol of GST-HBZ-bZIP (lane 3). Bound CREB-bZIP protein was
detected by Western blot analysis. A fraction of the input protein (8%) is shown in lane 1, and protein standards (in kilodaltons) are indicated at
the left. 35S-labeled ATF-1 was incubated with either GST (10 pmol, lane 5) or GST-HBZ-bZIP (10 pmol, lane 6). Bound ATF-1 was detected
by PhosphorImager analysis. A fraction of the input protein (20%) is shown in lane 4. (H) HBZ-bZIP disrupts CREB homodimerization. In the
left panel, GST (10 pmol) and GST-CREB (10 pmol) were incubated with 5 l of 35S-labeled CREB (lanes 2 and 3, respectively). In lanes 4 to
6, 10 pmol of GST-CREB was incubated with 5 l of 35S-labeled CREB and increasing amounts of 35S-labeled HBZ (5, 10 and 20 l). In lanes
7 to 8, 10 pmol of GST-CREB was incubated with 5 l of 35S-labeled CREB and increasing amounts of BSA (200, 400, and 800 ng). Complexes
were separated by SDS-PAGE, and bound CREB and HBZ were detected by PhosphorImager analysis. A fraction of the input protein (10%) is
shown in lane 1. In the right panel, GST (10 pmol, lane 2) and GST-CREB (10 pmol, lanes 3 to 5) were incubated with 5 l of 35S-labeled CREB
and 15 l of 35S-labeled HBZ (lane 4) or 35S-labeled HBZ-bZIP (lane 5). Complexes were separated by SDS-PAGE, and bound CREB and HBZ
were detected by PhosphorImager analysis. Fractions of the input of CREB (10%), HBZ (5%), and HBZ-bZIP (5%) proteins are shown in lanes
10, 15, and 16, respectively.
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CREB-bZIP. To ensure that the N-terminal domain of HBZ
does not interact with CREB, full-length HBZ and HBZ-
bZIP (aa 1 to 122) were labeled with 35S in an in vitro
transcription-translation reaction and combined with either
recombinant GST or GST-CREB. Figure 3F shows that,
whereas full-length HBZ bound to GST-CREB (lane 5), the
HBZ mutant lacking the bZIP domain did not (lane 6), con-
firming that HBZ interacts directly with CREB through its
bZIP domain.
We used GST-HBZ-bZIP to determine whether HBZ inter-
acts directly with CREM and ATF-1, as indicated by coimmu-
noprecipitation experiments (see Fig. 2B). Both proteins have
FIG. 4. HBZ displaces CREB from the viral CRE in vitro. (A) HBZ-bZIP reduces CREB and CREB-bZIP binding to the viral CRE. Gel shift
assays were used to analyze protein-DNA interactions. Binding reactions in lanes 1 to 11 contained 2.3 fmol of 32P-labeled viral CRE 3 probe with
0.16 pmol of CREB-bZIP (lanes 2 to 6) or 0.16 pmol of full-length CREB (lanes 7 to 11). Binding reactions in lanes 12 to 17 contained 3 fmol
of 32P-labeled UAS probe (lanes 12 to 17) with 0.35 pmol of Gal4-VP16 (lanes 13 to 17). The reactions shown in lanes 3 to 6 and 8 to 11 also
contained increasing amounts of HBZ-bZIP (0.02, 0.04, 0.08, and 0.16 pmol) and in lanes 14 to 17 (0.044, 0.09, 0.175, and 0.35 pmol). Positions
of the free probe and relevant protein-DNA complexes are labeled. The minor bands that migrated below the major CREB homodimer are
truncated forms of CREB present in the purified preparation. The slower-migrating complexes in CREB-bZIP lanes are CREB-bZIP aggregates
typically observed with high concentrations of protein (represented by asterisks). (B) HBZ-bZIP does not reduce CREB and CREB-bZIP binding
to the viral CRE. Binding reactions contained 6.8 fmol of 32P-labeled viral CRE 3 probe (lanes 1 to 12) with 0.08 pmol of CREB (lanes 2 to 6)
and 0.12 pmol of CREB-bZIP (lanes 8 to 12). The reaction shown in lane 3 also contained 0.8 pmol of HBZ-bZIP, and the reactions shown in
lanes 4 to 6 contained increasing amounts of HBZ-bZIP (0.8, 1.6, and 2.4 pmol). The reaction shown in lane 9 also contained 1.2 pmol of
HBZ-bZIP, and the reactions shown in lanes 10 to 12 contained increasing amounts of HBZ-bZIP (1.2, 1.8, and 2.4 pmol). (C) Specificity of
CREB and CREB-bZIP binding to the viral CRE. Binding reactions contained 6.8 fmol of 32P-labeled viral CRE 3 probe (lanes 1 to 8) with 0.2
pmol of CREB (lanes 2 and 4) and 0.5 pmol of CREB-bZIP (lanes 5 to 7). An antibody directed against the bZIP domain of CREB (500 ng, lanes
3 and 6) or an antibody against histone H3 (500 ng, lanes 4 and 7) were added in the reactions. (D) Purified proteins used in gel shift assays. Purified
CREB (lane 2), CREB-bZIP (lane 3), and HBZ-bZIP (lane 4) are shown by Coomassie blue staining after SDS-PAGE. Protein standards (in
kilodaltons) are indicated in lane 1. (E) HBZ-bZIP does not displace CREB-bZIP prebound to the viral CRE. Binding reactions contained 6 fmol
of 32P-labeled viral CRE 3 probe with 0.16 pmol of the CREB-bZIP (lanes 2 to 13). Increasing amounts of HBZ-bZIP (0.04, 0.08, 0.16, 0.32, and
0.64 pmol) were added at the same time as CREB and DNA (lanes 3 to 7) or 30 min after CREB and DNA (lanes 9 to 13). The positions of the
free probe and relevant protein-DNA complexes are labeled. The slower-migrating complexes in CREB-bZIP lanes are CREB-bZIP aggregates
typically observed with high concentrations of CREB-bZIP (represented by asterisks).
1548 LEMASSON ET AL. J. VIROL.
bZIP domains similar to that of CREB (53), and interactions
with HBZ should, therefore, occur through the bZIP domains.
As expected, CREM-Ia-bZIP and ATF-1 both interacted with
GST-HBZ-bZIP (Fig. 3G, lanes 3 and 6), but not GST alone
(Fig. 3G, lanes 2 and 5).
To then determine whether HBZ binding disrupts the
CREB homodimer, we tested the ability of HBZ to compete
with CREB for binding to GST-CREB. GST-CREB was com-
bined with 35S-labeled CREB alone (Fig. 3H, lane 3), or in the
presence of increasing amounts of 35S-labeled full-length HBZ
(Fig. 3H, lanes 4 to 6). The formation of the HBZ/GST-CREB
complex reduced the amount of CREB homodimer in a dose-
dependent manner. In contrast, addition of increasing amounts
of BSA did not affect CREB binding (Fig. 3H, lanes 7 to 9).
Furthermore, the HBZ-bZIP did not disrupt the CREB ho-
modimer (lane 14), suggesting that the bZIP domain of HBZ
is required for this effect.
HBZ inhibits CREB binding on viral CRE in vitro. Since
HBZ interacts with the CREB-bZIP domain, we were inter-
ested in determining whether HBZ inhibits the ability of
CREB to bind the viral CRE DNA. We performed gel shift
assays to analyze protein-DNA complexes using the third viral
CRE from the HTLV-1 promoter as the DNA probe. The
recombinant proteins used for these assays are shown in Fig.
4D (HBZ-bZIP is shown in Fig. 3C). As expected, CREB
formed a complex with the viral CRE (Fig. 4A, lane 7). How-
ever, when increasing amounts of HBZ-bZIP were incorpo-
rated into the binding reaction, the DNA/CREB complex was
diminished in a dose-dependent manner (Fig. 4A, lanes 8 to
11). We performed parallel experiments with CREB-bZIP
since CREB and HBZ interact via their bZIP domains (see
Fig. 3E). Similar to full-length CREB, the bZIP domain
formed a complex with the viral CRE (Fig. 4A, lane 2). Again,
titration of HBZ-bZIP into the binding reaction led to a re-
duction of DNA/CREB-bZIP complexes (Fig. 4A, lanes 3 to
6). To confirm that the effect of HBZ-bZIP on CREB binding
was specific, we attempted to disrupt the complex formed be-
tween the GAL4-VP16 protein and its UAS DNA-binding site
using HBZ-bZIP (Fig. 4A, lane 13). The addition of HBZ did
not affect GAL4-VP16 binding to the UAS site (Fig. 4A, lanes
14 to 17).
The specificity of HBZ-bZIP in inhibiting the formation of
the DNA/CREB and DNA/CREB-bZIP complexes was tested
by substituting HBZ-bZIP with other proteins in gel shift as-
says. Figure 4B shows that, unlike HBZ-bZIP, HBZ-bZIP did
not affect the binding of CREB (lanes 4 to 6) or CREB-bZIP
(lanes 10 to 12) to the viral CRE. Similar results were obtained
using BSA in place of HBZ-bZIP (data not shown). These
results demonstrate that HBZ-bZIP specifically inhibits the
ability of CREB to bind to an HTLV-1 viral CRE sequence. In
agreement with this result, we also found that the DNA bind-
ing of the Tax-CREB complex was inhibited in the presence of
HBZ-bZIP (data not shown).
Gel shift complexes consisting of full-length CREB or its
bZIP domain and the viral CRE have been characterized (21).
However, we confirmed the protein composition of these com-
plexes by supershift using an antibody directed against the
bZIP domain of CREB (Fig. 4C, lanes 3 and 6). An antibody
that does not recognize CREB (anti-histone H3) did not su-
pershift the complexes (lanes 4 and 7).
In addition, we were interested in testing whether HBZ-
bZIP displaces CREB from a preformed protein-DNA com-
plex, since complexes formed between c-Jun and the AP-1
binding site are not disrupted by the subsequent addition of
HBZ (5). In the experiments shown in lanes 2 to 7 of Fig. 4E
(and in experiments above), CREB and HBZ were added
FIG. 5. HBZ displaces Tax and CREB from the HTLV-1 promoter in vivo. (A) HBZ represses Tax-mediated transcriptional activation from
the HTLV-1 promoter. CHOK1-Luc cells were electroporated with pSG-Tax (10 g) in the absence or presence of pcDNA-HBZ-MycHis (10 g).
Luciferase assays were performed 24 h after transfection. The reported values are the average luminescence from three independent experiments,
and the standard error is indicated. (B) HBZ disrupts Tax and CREB binding at the HTLV-1 promoter. ChIP analysis was performed at 24 h
posttransfection on the same transfected cells used in panel A. Real-time PCR was used to quantify the amount of viral promoter DNA in each
immunoprecipitation. The levels of Tax and CREB binding in the presence of Tax and HBZ were normalized to binding in the presence of Tax
alone (set to 1). The graph is the average  the standard error from three independent ChIP experiments. (C) Tax and HBZ are expressed after
transfection. Western blot analysis was performed at 24 h posttransfection with whole-cell extracts from one experiment used in panels A and B.
The membrane was probed with anti-Tax and anti-Myc antibodies.
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simultaneously to the DNA. However, when CREB-bZIP was
prebound to the viral CRE DNA, the complex was refractory
to disruption by HBZ (Fig. 4E, lanes 9 to 13). These results
indicate that once CREB is bound to the DNA, the complex is
resistant to HBZ inhibition.
HBZ displaces Tax and CREB from the HTLV-1 promoter
in vivo. We were interested in correlating HBZ inhibition of
CREB binding to the viral CRE in vitro with the ability of
HBZ to repress Tax-mediated HTLV-1 transcription in living
cells. To perform these experiments, we analyzed protein bind-
ing at the viral promoter in CHOK1-Luc cells that carry two to
four genomically integrated copies of the HTLV-1 promoter
(U3 region) cloned upstream of the luciferase gene (47). Cells
were transfected with the Tax expression plasmid or cotrans-
fected with both the Tax and the HBZ expression plasmids.
Luciferase assays confirmed that HBZ significantly reduced
Tax transactivation from the integrated promoter (Fig. 5A).
Using this system we have previously shown by ChIP assays
that Tax, when expressed in the absence of HBZ, bound to the
integrated HTLV-1 long terminal repeat and promoted the
recruitment of CREB (36). In Fig. 5B, we show that the coex-
pression of HBZ led to a reduction in Tax binding and, to a
lesser extent, CREB binding (Fig. 5B). Overall, HBZ expres-
sion displaced more than 50% of Tax and ca. 25% of CREB
from the HTLV-1 promoter. These results correlate the HBZ
repression of Tax-dependent HTLV-1 transcription with a re-
duction in Tax and CREB from the viral promoter. Western
blot analysis confirmed that Tax and HBZ were expressed in
transfected cells (Fig. 5C).
HBZ inhibits CREB binding on cellular CREs. We wanted
to determine whether HBZ also represses CREB transactiva-
tion from a cellular CRE. To address this question, we used a
reporter plasmid containing three tandem copies of the con-
sensus cellular CRE cloned upstream of a core promoter (the
pminLuc-cellular CRE) (20). This reporter plasmid was trans-
fected into CEM cells that were subsequently treated with fors-
kolin to activate CREB (or a related factor) (20). As shown in Fig.
6A, the addition of forskolin to the culture medium produced a
20-fold increase in luciferase activity. However, cotransfection of
pcDNA-HBZ-MycHis reduced the activation by fourfold, dem-
onstrating that HBZ represses CREB activation from a cellular
CRE. As expected, cotransfection of pcDNA-HBZATG did not
reduce forskolin-mediated activation.
We then examined the effect of HBZ-bZIP on CREB-bZIP
binding to a cellular CRE by using a gel shift assay. Unlike the
viral CRE, the cellular CRE probe used in these experiments
consists of the complete octanucleotide consensus CRE se-
quence. As expected, CREB-bZIP was able to bind to the
cellular CRE in the absence of HBZ-bZIP (Fig. 6B, lane 2).
However, the addition of increasing amounts of HBZ-bZIP to
the binding reaction inhibited CREB binding to the cellular
CRE (Fig. 6B, lanes 3 to 5). In contrast, increasing amounts of
HBZ-bZIP did not affect binding (lanes 9 to 11).
DISCUSSION
This study shows that the HBZ protein, encoded by the
HTLV-1 retrovirus, abrogates virion production by repressing
viral transcription. These data corroborate our previous report
demonstrating that HBZ represses transcription driven from
the HTLV-1 promoter and, more specifically, represses tran-
scription mediated through the viral CREs (17). We have pro-
vided further insight into the mechanism of HBZ-mediated
repression by characterizing an interaction between HBZ and
FIG. 6. HBZ disrupts CREB binding at a cellular CRE. (A) HBZ represses CREB transactivation from a minimal promoter carrying only the
cellular CREs. The pminLuc-cellular CRE reporter plasmid (400 ng) was transfected into CEM T cells that were subsequently treated with
forskolin (20 M for 4 h) as indicated or dimethyl sulfoxide (carrier). pcDNA-HBZ-MycHis (400 ng) and pcDNA-HBZATG (400 ng) were
cotransfected with the reporter plasmid as indicated. Reported values are the average luminescence from two experiments performed in duplicate
and are representative of four independent experiments. The standard error is indicated. (B) HBZ-bZIP displaces CREB-bZIP from a cellular
CRE. Binding reactions in lanes 1 to 14 contained 6 fmol of 32P-labeled cellular CRE probe with 0.12 pmol of CREB-bZIP (lanes 2 to 5 and lanes
7 to 14). Reactions in lanes 3 to 5 also contained increasing amounts of HBZ-bZIP (0.6, 1.2, and 1.8 pmol). Reactions in lane 8 also contained
1.2 pmol of HBZ-bZIP, and lanes 9 to 11 also contained increasing amounts of HBZ-bZIP (1.2, 1.8, and 2.4 pmol). An antibody directed against
the bZIP domain of CREB (500 ng, lane 13) or an antibody against histone H3 (500 ng, lane 14) were also added in the reactions. The positions
of the free probe and relevant protein-DNA complexes are labeled.
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the cellular transcription factor CREB. This finding is of par-
ticular interest since CREB appears to be the primary ATF/
CREB member involved in Tax-mediated HTLV-1 transcrip-
tion (8). We demonstrated that HBZ binds directly to CREB
and that the interaction is mediated via the bZIP domain of
each protein.
The consequence of this interaction is the inhibition of
CREB binding to a viral CRE sequence from the HTLV-1
promoter in vitro. However, once formed, the CREB/viral
CRE complex displayed resistance to subsequent challenge
with HBZ. HBZ also displaced CREB and Tax from the
HTLV-1 promoter in cells containing genomically integrated
copies of the HTLV-1 promoter. Intriguingly, the apparent
decrease in binding at the viral promoter was greater for Tax
than for CREB, even though HBZ does not directly interact
with Tax (17). This phenomenon could be due to the potential
for HBZ to disrupt additional bZIP proteins from forming a
complex with Tax and the viral CREs. In this scenario, more
molecules of Tax than CREB would be prevented from binding
the promoter. Indeed, several ATF/CREB members have been
shown to participate in Tax-mediated transcription and form a
complex with Tax at the promoter. Among these, we showed
that CREB-2 is inhibited by HBZ expression (17). Further-
more, results from immunoprecipitation experiments (shown
in Fig. 2B) and GST pull-down assays (shown in Fig. 3G)
indicate that HBZ can additionally interact with either ATF-1
or CREM, both of which have been shown to function in
Tax-mediated HTLV-1 transcription (23).
An important common denominator in the pathogenesis of
the various HTLV-1-induced clinical syndromes appears to be
HTLV-1 gene expression, especially Tax expression (56). Al-
though the majority of infected individuals remain asymptom-
atic throughout their lifetime, ca. 5% develop inflammatory
diseases and another 2 to 3% develop ATL (4). It is well
established that transcription of the proviral genome is highly
regulated in vivo (50). Indeed, HTLV-1 RNA is expressed in
only 10% of HTLV-1-infected lymphocytes (46). An early in-
duction of latency in HTLV-1-bearing T cells was also ob-
served in experimentally infected squirrel monkeys (29). The
precise mechanisms responsible for HTLV-1 latency remain
unclear, but transcription of the viral genome can be induced
in lymphocytes from ATL patients, HAM/TSP patients, and
asymptomatic carriers by mitogenic stimulation of the cells in
vitro (9), suggesting that the viral promoter remains functional.
Based on our data, we propose that HBZ may play a role in
viral latency by suppressing HTLV-1 transcription and Tax
expression, which is supported by a recent report (3). HBZ
expression is not the only mechanism involved in this tight
control of HTLV-1 transcription. This control must require a
combination of events that can act in concert, including the
action of other HTLV-1-encoded proteins (45, 57), host factors
(10, 12, 25, 35, 40), and epigenetic modifications (54). The
repression of viral transcription, and therefore HTLV-1-anti-
gen expression, may be a significant advantage to the virus in
the infected cell by preventing its detection through a cytotoxic-
T-lymphocyte response.
In addition to disrupting CREB recruitment to the HTLV-1
promoter, HBZ may also repress cellular genes that are acti-
vated by CREB. In vitro, we found that HBZ inhibited the
binding of CREB to a consensus cellular CRE. In cells, HBZ
also repressed luciferase expression mediated by three tandem
cellular CREs upstream of a core promoter. These results are
of importance since CREB has been shown to be involved in
numerous cellular processes, including cell survival. However,
based on the inability of HBZ to displace CREB from pre-
formed CREB/DNA complexes, we suspect that HBZ only
represses the expression of cellular genes that utilize a mech-
anism involving CREB recruitment. Genes that have CREB
bound to the promoter would not be affected by HBZ, al-
though the off-rate of CREB from these sites may dictate the
actual degree of HBZ inhibition. Therefore, it is possible that
HBZ will inhibit the expression of only a subset of genes that
recruit CREB for activation, since the results of recent studies
show that CREB is constitutively bound to many sites within
the genome (11).
In conclusion, the HBZ protein represses HTLV-1 tran-
scription and is potentially involved in the deregulation of
cellular gene transcription. We and others recently demon-
strated that another isoform of HBZ is expressed in HTLV-1-
infected cells, HTLV-1 carriers, ATL cells lines, and fresh ATL
cell samples, and some of these samples lack Tax expression (7,
43, 52). Furthermore, a recent study showed that the HBZ
transcript is able to promote T-cell proliferation (52). There-
fore, the HBZ gene possesses unique functions at both the
protein and the transcript level that may contribute to leuke-
mogenesis.
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